February 28, 2022
While once deemed to have no medical value, there’s currently a race underway to study and gain FDA approval for the use of psychedelics as a mental health treatment. In this episode of the Business Group on Health Podcast, we speak with Olivia Goldhill, investigative reporter at STAT, about this race and why psychedelic therapy could be the biggest breakthrough in the mental health field in decades. We dive into why now, which products, and what psychedelic therapy approval could mean for patients and employers.
SPEAKERS
Olivia Goldhill | Investigative Reporter, STAT
LuAnn Heinen | Vice President, Business Group on Health
Duration 30 min
